How is a pulmonary tuberculosis cavity treated?

It is widely known that tuberculosis (TB) is an infectious disease, yet many are unaware of its different types. In fact, TB is classified into three main forms: primary, secondary, and hematogenously disseminated pulmonary tuberculosis. Among these, secondary pulmonary tuberculosis includes cavitary pulmonary tuberculosis—a form more commonly seen in adults and prone to recurrence. So, how is cavitary pulmonary tuberculosis treated?

How Is Cavitary Pulmonary Tuberculosis Treated?

Cavitary pulmonary tuberculosis can be treated through pharmacotherapy, drug susceptibility testing, and other approaches; however, drug therapy remains the cornerstone of treatment. For milder cases, first-line anti-tuberculosis drugs are typically used. If drug resistance develops, combination regimens involving second- or third-line drugs may be employed. Some patients require drug susceptibility testing to guide individualized treatment planning. With systematic, standardized treatment, the majority of cavities can eventually close.

Patients with cavitary pulmonary tuberculosis must adhere to maintenance therapy and receive appropriate nursing care, as this is a chronic condition. The total treatment duration generally exceeds six months, with the intensive phase lasting over one year—this extended regimen helps prevent relapse. Although treatment is prolonged, full recovery is achievable if patients consistently adhere to and complete the entire course of therapy. Family members should actively support the patient’s care and help foster determination and confidence in overcoming the disease.

During treatment, patients should emphasize nutritional support—consuming fruits and vegetables rich in vitamins—to enhance immune function. We hope this information proves helpful to you.